Abstract
Adenoviral vectors have proven to be valuable resources in the development of novel therapies aimed at targeting pathological conditions of the central nervous system, including Alzheimer’s disease and neoplastic brain lesions. Not only can some genetically engineered adenoviral vectors achieve remarkably efficient and specific gene delivery to target cells, but they also may act as anticancer agents by selectively replicating within cancer cells.
Due to the great interest in using adenoviral vectors for various purposes, the need for a comprehensive protocol for viral vector production is especially apparent. Here, we describe the process of generating an adenoviral vector in its entirety, including the more complex process of adenoviral fiber modification to restrict viral tropism in order to achieve more efficient and specific gene delivery.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Majhen D, Ambriovic-Ristov A (2006) Adenoviral vectors—how to use them in cancer gene therapy? Virus Res 119:121–133
Green NK, Seymour LW (2002) Adenoviral vectors: systemic delivery and tumor targeting. Cancer Gene Ther 9:1036–1042
He TC et al (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 95:2509–2514
Graham FL (1987) Growth of 293 cells in suspension culture. J Gen Virol 68:937–940
Lavappa KS, Macy ML, Shannon JE (1976) Examination of ATCC stocks for HeLa marker chromosomes in human cell lines. Nature 259:211–213
Stulberg CS et al (1970) The animal cell culture collection. In Vitro 5:1–16
Graham FL et al (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59–74
Coecke S et al (2005) Guidance on good cell culture practice. A report of the second ECVAM task force on good cell culture practice. Altern Lab Anim 33:261–287
Graham FL, Van der Eb AJ, Heijneker HL (1974) Size and location of the transforming region in human adenovirus type 5 DNA. Nature 251:687–691
Graham FL, Prevec L (1991) Manipulation of adenovirus vectors. Methods Mol Biol 7:109–128
Sambrook J (2001) Molecular cloning: a laboratory manual. In: Russell DW (ed) Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
He TC (2004) Adenoviral vectors. Curr Protoc Hum Genet Chapter 12: Unit 12.4
Kim JW et al (2013) An adenovirus vector incorporating carbohydrate binding domains utilizes glycans for gene transfer. PLoS One 8:e55533
Hanahan D, Gluzman Y (1984) Rescue of functional replication origins from embedded configurations in a plasmid carrying the adenovirus genome. Mol Cell Biol 4:302–309
Imler JL et al (1995) An efficient procedure to select and recover recombinant adenovirus vectors. Gene Ther 2:263–268
Chartier C et al (1996) Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol 70:4805–4810
Krougliak V, Graham FL (1995) Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants. Hum Gene Ther 6:1575–1586
Ng P, Graham FL (2002) Construction of first-generation adenoviral vectors. Methods Mol Med 69:389–414
Kanegae Y, Makimura M, Saito I (1994) A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 47:157–166
Maizel JV, White DO Jr, Scharff MD (1968) The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology 36:115–125
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Kim, J.W., Morshed, R.A., Kane, J.R., Auffinger, B., Qiao, J., Lesniak, M.S. (2016). Viral Vector Production: Adenovirus. In: Manfredsson, F. (eds) Gene Therapy for Neurological Disorders. Methods in Molecular Biology, vol 1382. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3271-9_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3271-9_9
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3270-2
Online ISBN: 978-1-4939-3271-9
eBook Packages: Springer Protocols